America Great Health (AAGH)
0.0026
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
America Great Health Gross Profit Margin (Quarterly): 87.32% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 87.32% |
December 31, 2023 | 90.65% |
September 30, 2023 | 98.72% |
June 30, 2023 | 99.96% |
March 31, 2023 | 99.52% |
December 31, 2022 | 79.08% |
September 30, 2022 | 47.05% |
June 30, 2022 | |
March 31, 2022 | 86.88% |
December 31, 2021 | -896.3% |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | 26.40% |
December 31, 2020 | |
September 30, 2020 | -5.88% |
June 30, 2020 | 38.45% |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | 17.96% |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 89.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-896.3%
Minimum
Dec 2021
99.96%
Maximum
Jun 2023
-12.34%
Average
82.98%
Median
Gross Profit Margin (Quarterly) Benchmarks
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 80.00% |
IGC Pharma Inc | 65.20% |
NovaBay Pharmaceuticals Inc | 68.19% |
Protalix BioTherapeutics Inc | 30.58% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -282.9% |
Profit Margin (Quarterly) | -240.9% |
Operating Margin (Quarterly) | -142.8% |
Return on Net Operating Assets | -305.2% |